Kenya drug regulator recalls a batch of JnJ children cough syrup
Written By : Ruchika Sharma
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2024-04-13 10:45 GMT | Update On 2024-04-13 10:45 GMT
Advertisement
Nairobi: Kenya's drug regulator said on thursday it is recalling a batch of Johnson & Johnson children's cough syrup, following Nigeria's recall of the same batch of medication under the Benylin Paediatric brand.
Nigeria's health regulator revealed that laboratory tests conducted on the syrup indicated a concerning level of diethylene glycol. This chemical has been associated with the deaths of numerous children in countries including Gambia, Uzbekistan, and Cameroon since 2022, marking one of the most severe episodes of poisoning linked to oral medication worldwide.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.